Castleark Management’s Calumet Specialty Products CLMT Stock Holding History

Castleark Management’s Portfolio CLMT Stock Details CLMT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q1	–	Sell	-94,670	Closed	-$1.89M	–	376
2015 Q4	$1.89M	Buy	94,670 +30,200	+47%	+$746K	0.06%	261
2015 Q3	$1.56M	Sell	64,470 -19,600	-23%	-$509K	0.05%	268
2015 Q2	$2.14M	Sell	84,070 -23,790	-22%	-$631K	0.06%	272
2015 Q1	$2.59M	Buy	107,860 +67,720	+169%	+$1.71M	0.06%	256
2014 Q4	$900K	Buy	+40,140	New	+$1.04M	0.02%	265
2013 Q4	–	Sell	-44,600	Closed	-$1.22M	–	327
2013 Q3	$1.22M	Buy	+44,600	New	+$1.4M	0.03%	236

Other funds holding CLMT

AAA

Adams Asset Advisors Dallas, Texas $882M AUM 42% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Stifel Financial St. Louis, Missouri $109B AUM 21.36% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

SOAMC

Spirit of America Management Corp Syosset, New York $530M AUM 36.47% 1-Year Est. Return

Castleark Management's CLMT Position: Q1 2016 in Review

Castleark Management sold out of Calumet Specialty Products (CLMT) in Q1 2016, closing a stake of 94,670 shares — an estimated $1.89M sold.

Castleark Management first reported a position in CLMT in Q3 2013 and held it in 6 quarters. The position peaked at $2.59M in Q1 2015. 111 funds tracked by Wall St. Rank hold CLMT as of Q1 2016.

Castleark Management reported no remaining Calumet Specialty Products position as of Q1 2016 after selling out during the quarter.
Castleark Management sold 94,670 Calumet Specialty Products shares in Q1 2016, an estimated $1.89M.
Castleark Management first reported a position in Calumet Specialty Products in Q3 2013 and held it in 6 quarters.
Castleark Management's Calumet Specialty Products position peaked at $2.59M in Q1 2015.
111 funds tracked by Wall St. Rank held Calumet Specialty Products as of Q1 2016.

Based on Castleark Management's 13F filing for Q1 2016, filed 17 May 2016.